Mitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseases

doi:10.4330/wjc.v6.i10.1091

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 6, Issue 10

This Article

Academic Content and Language Evaluation of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (11228)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-5) series, Tables (1-1) series.

Item

Count

PDF

704

WORD

342

HTML

6932

Figures (1-5)

325

Tables (1-1)

192

Sum=8495

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

1198

Download

1535

Sum=2733

Oct 26, 2014 (publication date) through Nov 5, 2024

Times Cited of This Article

Times Cited (49)

Journal Information of This Article

Publication Name

World Journal of Cardiology

ISSN

1949-8462

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Review

World J Cardiol. Oct 26, 2014; 6(10): 1091-1099
Published online Oct 26, 2014. doi: 10.4330/wjc.v6.i10.1091

Full Size Figure Download Figure

Figure 4 Crosstalk between mitochondrial Ca²⁺ handling and reactive oxygen species generation. PTP: Permeability transition pore; NOS: Nitric oxide synthase; ADP: Adenosine diphosphate; ATP: Adenosine triphosphate.

Citation: Ajith TA, Jayakumar TG. Mitochondria-targeted agents: Future perspectives of mitochondrial pharmaceutics in cardiovascular diseases. World J Cardiol 2014; 6(10): 1091-1099
URL: https://www.wjgnet.com/1949-8462/full/v6/i10/1091.htm
DOI: https://dx.doi.org/10.4330/wjc.v6.i10.1091